Perspective Therapeutics Inc. (CATX)
NYSE · Healthcare
Perspective Therapeutics Inc. Operating Income 2020–2025
Perspective Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Perspective Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -28.3 M, a 29.54% increase year-over-year.
- Perspective Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -120.0 M.
- Perspective Therapeutics Inc. annual operating income for 2025 was -113.6 M, a 70.01% increase from 2024.
- Perspective Therapeutics Inc. annual operating income for 2024 was -66.8 M, a 63.15% increase from 2023.
- Perspective Therapeutics Inc. annual operating income for 2023 was -40.9 M, a 453.93% increase from 2022.
- Perspective Therapeutics Inc. annual operating income for 2022 was -7.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Perspective Therapeutics Inc. Operating Income — FAQ
Perspective Therapeutics Inc. (CATX) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Perspective Therapeutics Inc.'s operating income?
Perspective Therapeutics Inc. (CATX) reported operating income of -$114M for fiscal 2025.
Where can I see CATX's operating income history?
The chart and table above show Perspective Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.